Overview To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis Status: Completed Trial end date: 2015-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare safety and efficacy of Perrigo's drug compared to an FDA approved drug in the treatment of actinic keratosis. Phase: Phase 3 Details Lead Sponsor: Padagis LLCPerrigo Company